25.7 C
New York
Thursday, June 4, 2026

Tag: supplement

Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.

NOON WORLD Launches Into 878 Target Doors; The Gummy Aisle Will Never Look the Same

NOON WORLD, the cognitive wellness brand redefining the functional gummy category, is now available in 878 Target stores nationwide.

Univest Securities, LLC Announces Closing of $8 Million Registered Direct Offering for its Client Hitek Global Inc. (NASDAQ: HKIT)

New York, June 03, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $8 million for its client Hitek Global Inc. (NASDAQ: HKIT) (the “Company”), a China-based information technology consulting and solutions service provider.

Jianzhi Education Technology Group Company Limited Announces Closing of $5 Million Registered Direct Offering

BEIJING, June 3, 2026 /PRNewswire/ -- Jianzhi Education Technology Group Company Limited (NASDAQ: JZ) (the "Company" or "Jianzhi") today announced the closing of its...

TransAlta Announces the Acquisition of Two Fully-Contracted Gas Assets in Colorado and Concurrent $350 Million Bought Deal Offering of Common Shares

The short form base shelf prospectus is accessible, and the final prospectus supplement will be accessible within two business days, through SEDAR+.

PROREIT Announces Agreements to Acquire 17 Industrial Assets for an Aggregate Purchase Price of $136.8 Million, $72.5 Million Bought Deal Public Offering of Trust...

The base shelf prospectus is accessible, and the prospectus supplement will be accessible within two business days, through SEDAR+

The $1 Billion Bet to Take Fusion Public

Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary — Fusion has been "thirty years away" for...

The $1 Billion Bet to Take Fusion Public

Issued on behalf of General Fusion Inc.VANCOUVER, BC, June 3, 2026 /CNW/ -- Equity-Insider.com News Commentary -- Fusion has been "thirty years away" for...

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) -- Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026.

TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public...

TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK

SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the commencement of an underwritten public...

Nutrition Business Journal Releases 2026 Supplement Business Report: U.S. Market Surges Toward $100 Billion Milestone

Nutrition Business Journal Releases 2026 Supplement Business Report, Comprehensive Industry Analysis Driving Growth in Dietary Supplements

Brookfield Renewable to Issue C$150 Million of 5.75% Preferred Units

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION TO THE UNITED STATES

AbbVie Announces European Commission Approval of AQUIPTA® (atogepant) for the Acute Treatment of Migraine in Adults

AQUIPTA® (atogepant) is now approved in the European Union for the acute treatment of migraine in adults, with or without aura, and for the...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSupplement